Resmed RMD · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
235.74
+0.19%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Resmed
From its filings with the US Securities and Exchange Commission
Resmed is based in San Diego, California and is incorporated in Delaware. Its shares trade on NYSE under the ticker RMD. It is a member of the S&P 500. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 30 June 2026, it reported revenue of $5.65bn and net income of $1.52bn. At that date it held total assets of $8.97bn and shareholders' equity of $6.59bn.
We are a global leader in digital health and cloud-connected medical devices. We design innovative technology to empower people to live happier, healthier lives. Our artificial intelligence, or AI, powered digital health solutions, cloud-connected devices and intelligent software are designed to make home healthcare more personalized, accessible and effective. By enabling better care, our products improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems.
Following our formation in 1989, we commercialized a continuous positive airway pressure, or CPAP, treatment for obstructive sleep apnea, or OSA, which was the first successful non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a mask, to prevent collapse of the upper airway during sleep. Since the development of CPAP, we have expanded our business by developing or acquiring a number of innovative products and solutions for a broad range of sleep and related breathing health disorders including technologies to be applied in medical and consumer products, life support and ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, and dental devices. In addition, we are a leading provider of cloud-based health applications, software and devices designed to provide connected care, enabling clinicians to manage more patients efficiently and effectively, as well as enabling and encouraging patients’ long-term adherence to and satisfaction with their therapy.
Quoted from its 10-K, filed 13 Aug 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 1 Jun 1995
- Employees
- 11,370
- Website
- resmed.com ↗
- Head office
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Michael FarrellChairman of the Board, Chief Executive Officer, since 2005$14.7m
- Dr. Peter FarrellFounder and Chairman Emeritus, since 2023$673,267
- Mr. Brett SandercockChief Financial Officer$3.6m
- Mr. Michael RiderGlobal General Counsel, Company Secretary$2.3m
- Mr. Justin LeongChief Product Officer$3.9m
- Mr. Ronald TaylorLead Independent Director$369,909
- Ms. Carol BurtIndependent Director$366,719
- Mr. Jan De WitteIndependent Director$329,909
- Mr. Christopher DeloreficeIndependent Director$377,745
- Ms. Karen DrexlerIndependent Director$349,909
- Ms. Harjit GillIndependent Director$333,099
- Mr. John HernandezIndependent Director$329,909
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 86
- Environment
- 99
- Social
- 99
- Governance
- 59
- Direct emissions (scope 1)
- 4,236 t
- Energy emissions (scope 2)
- 24,422 t
- Women in the workforce
- 53.69%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Resmed Inc has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and is recognized as a leader in the sleep and respiratory care industry. This gives Resmed a competitive advantage over its rivals. Additionally, Resmed has a comprehensive range of products and solutions that cater to different customer needs, ensuring a diverse customer base. Moreover, the company invests heavily in research and development, allowing it to innovate and bring cutting-edge technologies to the market. This positions Resmed as an industry pioneer with a constant stream of new and improved products.
Weaknesses
- Despite its strengths, Resmed Inc also faces some weaknesses. One of the major weaknesses is the heavy reliance on a limited number of suppliers for key components. Any disruption in the supply chain can significantly affect Resmed's production and distribution capabilities. Additionally, Resmed's high dependence on Medicare and reimbursement policies creates vulnerability to changes in healthcare regulations. This can impact the company's profitability and restrict market expansion.
Opportunities
- Resmed Inc has numerous opportunities in the market that it can capitalize on. With the growing awareness of sleep apnea and other respiratory conditions, there is a significant demand for effective treatment devices and solutions. Resmed can expand its market share by targeting emerging markets where awareness and access to healthcare are increasing. Furthermore, the company can explore partnerships and collaborations with healthcare providers to enhance product distribution and reach a larger customer base. The continuous advancements in technology also present opportunities for Resmed to develop and introduce more advanced, user-friendly, and connected solutions.
Threats
- Resmed Inc faces several threats that could impact its business operations. One of the main threats is intense competition from both established players and new entrants in the sleep and respiratory care industry. Price wars, rapid technological advancements, and changing consumer preferences make it crucial for Resmed to continuously innovate and differentiate its products. Another threat is the potential impact of economic downturns, as disposable income and healthcare spending may decrease. Finally, strict regulations and compliance requirements can pose challenges to Resmed's ability to expand into new markets and launch products in a timely manner.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.